Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)

NCT04971161 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Skin Ulcer Venous Stasis Chronic

Interventions

BIOLOGICAL: allo-APZ2-CVU
DRUG: Placebo

Sponsor

RHEACELL GmbH & Co. KG

Collaborators

[object Object]